Monday, November 23, 2026

“Rare Cancer Found in Mom’s Lung”: Sisters Chaeryeong and Lee Chae-yeon Share Update on Their Mother’s Cancer Treatment [Health Talk]

Input
2026-11-23 04:40:00
Updated
2026-11-23 04:40:00
Photo: MBC’s “Omniscient Interfering View”

[Financial News] ITZY member Chaeryeong said her mother had been diagnosed with sarcoma, a rare cancer, and was undergoing treatment. She said cancer had been found in her lung, but tests were continuing because the primary site, where the cancer first developed, had not been identified. Sarcoma arises in connective tissues such as muscle, fat and blood vessels, and can also spread to the lungs from other organs, making it important to identify where it originated.

In episode 425 of MBC’s “Omniscient Interfering View,” which aired on the 21st, Chaeryeong was shown making a video call to her mother with her older sister, singer Lee Chae-yeon.
Their mother told her two daughters, “I used to wish for you both to do well, but now I wish I could see you more often. Mom has changed her mind. My feelings have changed, haven’t they?”
Chaeryeong said her mother was suddenly diagnosed with cancer this summer. She said, “She is still receiving treatment. They are still looking for the primary site. It’s a somewhat rare case. It’s a sarcoma found in the lung. Usually, when sarcoma is found in the lungs, it has spread from somewhere else, but Mom’s was first found in her lung, so they’re continuing to look with CT scans to find where it started.”
At the time of the diagnosis, Chaeryeong was overseas on a world tour. Lee Chae-yeon, who was in South Korea, cared for their hospitalized mother while keeping up with her schedule.
Lee Chae-yeon recalled, “I had a really hard time after Mom got sick. I was busy, but Mom was in the hospital, and I pretty much went there straight after work. I even started work there. That was when you were overseas.”
Chaeryeong also knew that her mother had gone to the hospital, but said she was too busy to contact her for two days. She said she couldn’t eat anything for two days and thought, “I might have to say goodbye to Mom sooner than I thought,” describing how she felt when she heard about the cancer diagnosis.
She later said the family had started “Setlog,” where they record their daily lives together. It was to keep up with one another and preserve family memories. Chaeryeong also said she plans to get her driver’s license next year so she can take her mother to the hospital herself.

Rare-cancer sarcoma: how is it different from ordinary lung cancer?

The sarcoma found in Chaeryeong’s mother is a malignant tumor that arises in tissues that support the body, such as muscle, fat, blood vessels and the tissues surrounding nerves.
According to the U.S. National Cancer Institute (NCI), soft-tissue sarcomas can arise in various parts of the body, and their growth rates and patterns of metastasis vary depending on their histological type.
Sarcoma arises in different tissues from ordinary lung cancer. Cancer commonly called lung cancer usually begins in epithelial cells in the bronchi and alveoli, whereas sarcoma arises in connective tissue.
Soft-tissue sarcomas often spread to the lungs. However, finding sarcoma in the lung alone is not enough to determine whether it spread from another organ or is a primary sarcoma that first developed in the lung.
Chaeryeong said only that they were looking for her mother’s exact primary site; she did not confirm that the cancer began in the lung.
Sarcoma: how do doctors find where it first developed?

When sarcoma is found in the lung, it is necessary to determine whether the tumor originated in the lung itself or began elsewhere and spread to the lung.
According to the National Cancer for Knowledge and Information Center of the National Cancer Center, malignant soft-tissue sarcomas often spread to the lungs through the bloodstream. Primary sites can be found in various parts of the body, including the limbs, trunk and retroperitoneum, the space deep in the abdomen.
Computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) are used to identify the primary site. Analyzing the form and characteristics of cancer cells through a biopsy is also important.
The U.S. National Cancer Institute (NCI) advises that sarcoma types be determined based on biopsy results, and that imaging tests be used to identify where the cancer originated and how far it has spread.
However, the primary site may remain unidentified even after detailed testing. The exact type and stage of sarcoma in Chaeryeong’s mother, and whether it has spread, have not been disclosed.
Sarcoma treatment varies by type and whether it has spread

Treatment for sarcoma varies depending on where it originated, its histological type and size, and whether it has spread.
According to the National Cancer Center, surgery is the main treatment for soft-tissue sarcoma, with radiation therapy and chemotherapy used in combination depending on the patient’s condition.
If the cancer has spread to other organs, the treatment plan is determined based on the extent of the spread and the patient’s overall condition. Some patients also undergo surgery to remove metastatic lesions.
The NCI explains that sarcomas have many histological types, making an accurate diagnosis important for planning treatment. It recommends determining treatment for rare sarcomas by considering pathology findings and imaging results together.

[email protected] Han Seung-gon Reporter